featured
Adjuvant Abemaciclib Added to Endocrine Therapy for High-Risk Early Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study
Ann. Oncol 2022 Jun 01;33(6)616-627, HS Rugo, J O'Shaughnessy, F Boyle, M Toi, R Broom, I Blancas, M Gumus, T Yamashita, YH Im, P Rastogi, F Zagouri, C Song, M Campone, B San Antonio, A Shahir, M Hulstijn, J Brown, A Zimmermann, R Wei, SRD Johnston, M Reinisch, SM TolaneyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.